These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8854194)

  • 21. Clinical experience with ioversol for angiography.
    Bettmann MA
    Invest Radiol; 1989 Jun; 24 Suppl 1():S61-6. PubMed ID: 2687199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of efficacy and tolerability of ioversol in intravenous urography. A comparative double-blind study versus iopamidol].
    Joffre F; Rousseau H; Aziza R
    Ann Radiol (Paris); 1992; 35(4 Pt 2):288-92. PubMed ID: 1296494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-osmolality contrast media: dosage comparison of ioversol and iohexol for cranial computed tomography.
    Kuhn MJ; Long SD; DeSio MA
    Comput Med Imaging Graph; 1991; 15(6):403-6. PubMed ID: 1773412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind clinical study comparing the safety, tolerance and efficacy of ioversol and iohexol in intravenous urography.
    Colthurst JR; Chan O; Creagh M; Gordon P; Guy R; Muncey F; Ayers AB
    Clin Radiol; 1990 Sep; 42(3):174-6. PubMed ID: 2208927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind study of a new nonionic contrast agent for digital subtraction arteriography.
    Weiss JP; McLean GK; Modic MT; Rees CR; Higashida RT
    Invest Radiol; 1994 May; 29 Suppl 1():S84-92. PubMed ID: 8071051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized double-blind trial of ioversol and iopamidol in contrast-enhanced computed body tomography.
    Sage MR; Evill CA; Fon GT
    Invest Radiol; 1989 Jun; 24 Suppl 1():S39-41. PubMed ID: 2687194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of iopromide for excretory urography.
    Newhouse JH; Landman J; Lang E; Amis ES; Goldman S; Khazan R; Leder R; Hedgcock M
    Invest Radiol; 1994 May; 29 Suppl 1():S68-73. PubMed ID: 8071049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethiodized poppyseed oil versus ioversol for image quality and adverse events in hysterosalpingography: a prospective cohort study.
    Tan Y; Zheng S; Lei W; Wang F; Jiang S; Zeng T; Zhou B; Hong F
    BMC Med Imaging; 2019 Jun; 19(1):50. PubMed ID: 31234782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary study and clinical evaluation method of ioversol in angiocardiography--establishment of safety evaluation parameters and reliability of radiographic quality evaluation].
    Matsuyama S; Kuribayashi S; Ide M; Shigeta A; Umemura J; Harada J; Yamada T; Himi K; Takemoto A; Morimoto S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jun; 50(6):620-36. PubMed ID: 2235313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of viscosity and iodine concentration of nonionic radiographic contrast media on coronary arteriography in patients.
    Kern MJ; Roth RA; Aguirre FV; Beauman G; Vogel R
    Am Heart J; 1992 Jan; 123(1):160-5. PubMed ID: 1729820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind study comparing the safety, tolerability, and efficacy of ioversol-350 and iohexol-350 in coronary arteriography with left ventriculography.
    McGaughey MD; Remetz MS; Sharf-Bornhofen E
    J Invasive Cardiol; 1991; 3(6):272-7. PubMed ID: 10149109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
    Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind CT study comparing the safety and efficacy of iopentol and ioxaglate in paediatric patients.
    Sayegh N; Porée C; Baraton J; Skinningsrud K; Nantois C; Lallemand D
    Eur Radiol; 1996; 6(4):574-7. PubMed ID: 8798046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind study of a new nonionic contrast agent for cardiac angiography.
    Reagan K; Bettman MA; Finkelstein J; Ganz P; Grassi CJ
    Radiology; 1988 May; 167(2):409-13. PubMed ID: 3282261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of micronuclei in lymphocytes of patients undergoing excretory urography with ioversol.
    Cochran ST; Norman A
    Invest Radiol; 1994 Feb; 29(2):210-2. PubMed ID: 8169099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of low-osmolality contrast media for cranial CT: a dose comparison of two contrast agents.
    Kuhn MJ; Baker MR
    AJNR Am J Neuroradiol; 1990; 11(5):847-9; discussion 850-1. PubMed ID: 2120986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
    Rudnick MR; Davidson C; Laskey W; Stafford JL; Sherwin PF;
    Am Heart J; 2008 Oct; 156(4):776-82. PubMed ID: 18946896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ioversol 320: a new nonionic, water-soluble contrast medium for body computed tomography clinical trial.
    Kopecky KK; Becker GJ; Conces DJ
    Invest Radiol; 1989 Jun; 24 Suppl 1():S33-4. PubMed ID: 2687192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ioversol 300 and iopamidol 300 in "whole body" computed tomography. A double-blind clinical trial].
    Chagnaud C; Moulin G; Delannoy L; Gaubert JY; Haddad D; Bartoli JM; Kasbarian M
    Ann Radiol (Paris); 1992; 35(4 Pt 2):276-9. PubMed ID: 1296491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ioversol 350: clinical experience in skull x-ray computed tomography].
    Théron J; Paugam JP; Courthéoux P
    Ann Radiol (Paris); 1991; 34(6-7):413-7. PubMed ID: 1822666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.